Drugs News and Research

RSS

Anchor proteins inhibit a key metabolic driver involved in cancer and neuronal diseases

Certain anchor proteins inhibit a key metabolic driver that plays an important role in cancer and developmental brain disorders.

27 Jan 2021

Non-steroidal anti-inflammatory drugs reduce antibody and inflammatory responses to COVID-19

According to a new study, non-steroidal anti-inflammatory drugs (NSAIDs) decreased both inflammatory and antibody responses to SARS-CoV-2 infection in mice.

26 Jan 2021

Cancer cells can exchange and recombine their genetic material, shows study

Evolution within groups of tumor cells follows the principles of natural selection, as evolution in pathogenic microbes.

22 Jan 2021

SARS-CoV-2 virus may enter and replicate in human cells by targeting cellular processes

The SARS-CoV-2 virus may enter and replicate in human cells by exploiting newly-identified sequences within cell receptors, according to work from two teams of scientists.

22 Jan 2021

Researchers identify a new way to stop COVID-19 virus

While the world awaits broad distribution of COVID-19 vaccines, researchers at Ohio University just published highly significant and timely results in the search for another way to stop the virus -- by disrupting its RNA and its ability to reproduce.

22 Jan 2021

Venom of Tiger Rattlesnakes may advance genetic science

Among all rattlesnake species, the Tiger Rattlesnake has the simplest yet most lethal venom. Now, a new study performed by a team of researchers can describe the genetics behind the venomous bite of the Tiger Rattlesnake.

21 Jan 2021

Common insecticides affect the amount of night's sleep in bumblebees and fruit flies

Just like us, many insects need a decent night's sleep to function properly, but this might not be possible if they have been exposed to neonicotinoid insecticides, the most common form of insecticide used worldwide, suggests research by academics at the University of Bristol.

21 Jan 2021

Investigational antisense medicine lowers disease burden, reduces myeloma cell abundance in mice

Many patients with multiple myeloma, a type of blood cancer, eventually develop resistance to one treatment after another. That's in part because cancer stem cells drive the disease -- cells that continually self-renew. If a therapy can't completely destroy these malignant stem cells, the cancer is likely to keep coming back.

From UC San Diego 21 Jan 2021

Researchers define cancer invasion machinery orchestrated by cancer gene

Researchers at the University of Helsinki have defined a cancer invasion machinery, which is orchestrated by a frequently mutated cancer gene called Ras. When signaling from Ras protein becomes abnormally high, like it does in many cancers, this switches on the cellular machinery that helps the cancer cells to depart from the tissue from which the cells have developed.

20 Jan 2021

New method shows how pharmaceuticals induce cancer cell death

Cancer cells are smart when it comes to anti-cancer drugs, evolving and becoming resistant to even the strongest chemotherapies over time.

20 Jan 2021

Researchers develop more effective personalized immunotherapy for cancer patients

New research from CU Cancer Center member Jing Hong Wang, MD, PhD, and recent University of Colorado Immunology program graduate Rachel Woolaver, PhD, may help researchers develop more effective personalized immunotherapy for cancer patients.

15 Jan 2021

Targeting RNA splicing can trigger antiviral immune pathways in triple-negative breast cancers

Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.

15 Jan 2021

Study: Cattle feed yards emit synthetic chemical cocktails into the environment

A recent Point of Reference article, "The meat of the matter: Environmental dissemination of beef cattle agrochemicals," published in Environmental Toxicology and Chemistry, points at synthetic chemical cocktails being emitted from cattle feed yards into the environment and how they can impact our ecosystem and our health.

15 Jan 2021

Drugs News and Research

Anchor proteins inhibit a key metabolic driver involved in cancer and neuronal diseases

Non-steroidal anti-inflammatory drugs reduce antibody and inflammatory responses to COVID-19

Cancer cells can exchange and recombine their genetic material, shows study

SARS-CoV-2 virus may enter and replicate in human cells by targeting cellular processes

Researchers identify a new way to stop COVID-19 virus

Venom of Tiger Rattlesnakes may advance genetic science

Common insecticides affect the amount of night's sleep in bumblebees and fruit flies

Investigational antisense medicine lowers disease burden, reduces myeloma cell abundance in mice

Researchers define cancer invasion machinery orchestrated by cancer gene

New method shows how pharmaceuticals induce cancer cell death

Researchers develop more effective personalized immunotherapy for cancer patients

Targeting RNA splicing can trigger antiviral immune pathways in triple-negative breast cancers

Study: Cattle feed yards emit synthetic chemical cocktails into the environment

Using mass spectrometry to determine the sex of fingermarks

Protein phosphatase inhibition could contribute to the treatment of cancer, other diseases

New model can help identify potential drug targets for ulcerative colitis

Augmented response of immune system explains COVID-19 severity in patients with hypertension

Using proteomics to determine how long a corpse has been underwater

Study unravels the mystery of infectious virion formation

Scientific experts discuss the definition of fermented foods and beverages

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics